After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026 published in Annals of Oncology. In the UK, death rates from lung cancer have been falling among women for several years, although from a higher peak than those seen in the EU, but they have continued to rise among EU women during this time.

The American Cancer Society today released its annual “Cancer Statistics, 2026” and “Cancer Facts & Figures 2026” report — the first national snapshot of this year’s cancer trends. Experts from City of Hope^®, one of the country’s leading cancer research and treatment institutions, are available immediately for interviews to help interpret key trends and provide context for how these findings affect patients, families and the future of cancer care. We also have patients available for interviews.

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud university medical center and university hospital Bonn (UKB) in collaboration with researchers from Munich and Barcelona, shows that DNA analysis of colorectal polyps provides important additional information on the development of these polyps and colorectal cancer. This DNA analysis leads to better diagnostics and treatment and offers patients and their family members greater clarity. The results have now been published in Gastroenterology. 

Immunotherapy before and after surgery improves outcomes for patients with lung cancer

Researchers find that higher bacteria levels inside tumors promote treatment resistance in head and neck cancer

Promising targeted therapies for AML and colorectal cancer

New targets identified to prevent chronic neuropathic pain after nerve injury